The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients

Philipp S. Goerttler(University Hospital Ulm), Heike L. Pahl(University Medical Center Freiburg), E März(University Hospital Ulm), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Peter Johansson(Linköping University), Björn Andréasson(NU Hospital Group), H. Heimpel(University of Mannheim), Heinz Gisslinger(Medical University of Vienna), Cordula Steimle(University Hospital Ulm)

Blood

June 29, 2005

10.1182/blood-2005-04-1515

Cited by 97

Related Papers

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

|Blood|2012|596

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

|Journal of Clinical Oncology|2011|540

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

|Journal of Clinical Oncology|2012|461

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

|Blood|1994|458

Erythropoietin Treatment of Anemia Associated with Multiple Myeloma

|New England Journal of Medicine|1990|450